Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.190
+0.040 (1.86%)
At close: May 13, 2025, 4:00 PM
2.229
+0.039 (1.79%)
Pre-market: May 14, 2025, 8:23 AM EDT
Nuvation Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 47.98 | 35.72 | 42.65 | 101.1 | 132.42 | 29.76 | Upgrade
|
| Short-Term Investments | 413.7 | 466.97 | 568.56 | 559.92 | 632.97 | 186 | Upgrade
|
| Cash & Short-Term Investments | 461.68 | 502.69 | 611.21 | 661.01 | 765.39 | 215.75 | Upgrade
|
| Cash Growth | -22.66% | -17.76% | -7.53% | -13.64% | 254.76% | 81.50% | Upgrade
|
| Accounts Receivable | 0.41 | 12.72 | - | - | - | - | Upgrade
|
| Other Receivables | 5.05 | 3.57 | 3.7 | 2.49 | 3.04 | 1.09 | Upgrade
|
| Receivables | 5.46 | 16.29 | 3.7 | 2.49 | 3.04 | 1.09 | Upgrade
|
| Prepaid Expenses | 8.42 | 7.27 | 1.52 | 3.82 | 3.64 | 0.91 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 2.93 | Upgrade
|
| Total Current Assets | 475.57 | 526.26 | 616.43 | 667.32 | 772.07 | 220.68 | Upgrade
|
| Property, Plant & Equipment | 5.9 | 2.99 | 4.32 | 4.69 | 3.66 | 0.69 | Upgrade
|
| Other Intangible Assets | 4.41 | 4.62 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 6.62 | 6.76 | 0.73 | 0.14 | 0.42 | 0.42 | Upgrade
|
| Total Assets | 492.49 | 540.63 | 621.48 | 672.14 | 776.15 | 221.79 | Upgrade
|
| Accounts Payable | 10.54 | 6.35 | 2.21 | 2.14 | 3.93 | 2.17 | Upgrade
|
| Accrued Expenses | 23.89 | 32.15 | 9.65 | 9.7 | 11.74 | 4.38 | Upgrade
|
| Short-Term Debt | 5.69 | 6.28 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.89 | 1.66 | 1.97 | 1.21 | 0.86 | - | Upgrade
|
| Current Income Taxes Payable | - | 0.68 | 0.14 | 0.11 | 0.4 | - | Upgrade
|
| Current Unearned Revenue | 10.77 | 11.12 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 52.77 | 58.24 | 13.97 | 13.16 | 16.93 | 6.55 | Upgrade
|
| Long-Term Leases | 3.84 | 0.97 | 2.04 | 3.05 | 2.19 | - | Upgrade
|
| Long-Term Unearned Revenue | 13.61 | 15.57 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 2.8 | 2.05 | 0.35 | 0.85 | 11.04 | 0.16 | Upgrade
|
| Total Liabilities | 73.03 | 76.84 | 16.36 | 17.07 | 30.15 | 6.71 | Upgrade
|
| Common Stock | 1,383 | 1,374 | 947.75 | 927.6 | 909.99 | 289.48 | Upgrade
|
| Retained Earnings | -963.98 | -910.74 | -342.8 | -267 | -162.8 | -75.96 | Upgrade
|
| Comprehensive Income & Other | 0.55 | 0.57 | 0.18 | -5.53 | -1.19 | 1.56 | Upgrade
|
| Total Common Equity | 419.46 | 463.79 | 605.12 | 655.08 | 746 | 215.08 | Upgrade
|
| Shareholders' Equity | 419.46 | 463.79 | 605.12 | 655.08 | 746 | 215.08 | Upgrade
|
| Total Liabilities & Equity | 492.49 | 540.63 | 621.48 | 672.14 | 776.15 | 221.79 | Upgrade
|
| Total Debt | 11.41 | 8.92 | 4.01 | 4.26 | 3.06 | - | Upgrade
|
| Net Cash (Debt) | 450.26 | 493.78 | 607.21 | 656.75 | 762.34 | 215.75 | Upgrade
|
| Net Cash Growth | -24.13% | -18.68% | -7.54% | -13.85% | 253.34% | 81.50% | Upgrade
|
| Net Cash Per Share | 1.51 | 1.84 | 2.77 | 3.03 | 3.85 | 2.21 | Upgrade
|
| Filing Date Shares Outstanding | 340.26 | 338.68 | 219.05 | 218.8 | 219.06 | 217.65 | Upgrade
|
| Total Common Shares Outstanding | 339.84 | 337.84 | 219.05 | 218.63 | 217.95 | 412.96 | Upgrade
|
| Working Capital | 422.8 | 468.01 | 602.46 | 654.16 | 755.15 | 214.13 | Upgrade
|
| Book Value Per Share | 1.23 | 1.37 | 2.76 | 3.00 | 3.42 | 0.52 | Upgrade
|
| Tangible Book Value | 415.05 | 459.17 | 605.12 | 655.08 | 746 | 215.08 | Upgrade
|
| Tangible Book Value Per Share | 1.22 | 1.36 | 2.76 | 3.00 | 3.42 | 0.52 | Upgrade
|
| Machinery | - | 1.11 | 1.04 | 1.04 | 0.83 | 0.56 | Upgrade
|
| Leasehold Improvements | - | 0.35 | 0.34 | 0.32 | 0.24 | 0.24 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.